NEW DELHI: The Lung Health & Oncology National Conference 2024, held at the Ambedkar International Convention Centre, was inaugurated by Kamal Narayan, CEO of the IHW Council.
The event focused on advancements in lung cancer detection and treatment, drawing attention to the rising burden of the disease in India due to smoking, air pollution, and industrial exposure.
Mohammed Yahya, Director of the CEO’s office at Qure.ai, highlighted the transformative potential of artificial intelligence in early lung cancer diagnosis.
He discussed Qure.ai’s collaboration with AstraZeneca, emphasizing how their partnership could enhance precision in radiology and expedite diagnosis, even in resource-limited settings.
Adding to the event’s impactful discourse, Col Rajeev Mannali, CEO of SUT Pattom Super Speciality Hospital, shared insights about their Lung Cancer Free Kerala campaign. “With the support of the IHW Council and our robust infrastructure, I am optimistic about overcoming challenges and advancing lung health initiatives.”
The conference featured compelling discussions on cutting-edge diagnostic tools, including molecular biomarkers and advanced imaging technologies, underscoring the need for early detection to improve patient outcomes.
Experts like Dr. Saroj Das Majumder from AIIMS Bhubaneswar emphasised the urgent need to bridge awareness gaps and strengthen healthcare infrastructure to address late-stage diagnoses.
A highlight of the event was the panel discussion exploring barriers in lung cancer care, such as unequal access to advanced diagnostics and regional disparities. Solutions like India-specific guidelines and patient advocacy initiatives were proposed to improve equity in cancer care.
The conference concluded with a call to action for multidisciplinary collaboration, advocating for AI-driven innovations and personalized treatment approaches to transform the future of lung cancer management.